In December, Professor Erika Lietzan spoke at a pharmaceutical law conference hosted by the CREDIMI, a center for research relating to markets and international investment, at the school of law at the Université de Bourgogne in Dijon, France. She presented her research examining the impact of pharmaceutical regulation on effective patent life and discussed its implications for restoration of patent…